TCM
AMN icon

Tributary Capital Management’s AMN Healthcare AMN Stock Holding History

Tributary Capital Management’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Buy
598,497
+217,968
+57% +$4.14M 1.07% 46
2025
Q4 		$6M Sell
380,529
-35,426
-9% -$632K 0.59% 59
2025
Q3 		$8.05M Sell
415,955
-18,869
-4% -$369K 0.73% 60
2025
Q2 		$8.99M Sell
434,824
-55,700
-11% -$1.16M 0.8% 59
2025
Q1 		$12M Buy
490,524
+162,439
+50% +$4.17M 1.05% 53
2024
Q4 		$7.85M Buy
328,085
+95,204
+41% +$3.02M 0.61% 58
2024
Q3 		$9.87M Sell
232,881
-33,791
-13% -$1.77M 0.77% 58
2024
Q2 		$13.7M Buy
266,672
+87
+0% +$4.93K 1.13% 48
2024
Q1 		$16.7M Buy
266,585
+44,740
+20% +$3.04M 1.36% 40
2023
Q4 		$16.6M Sell
221,845
-5,833
-3% -$417K 1.4% 36
2023
Q3 		$19.4M Buy
227,678
+43,961
+24% +$4.17M 1.84% 16
2023
Q2 		$20M Sell
183,717
-3,207
-2% -$304K 1.8% 12
2023
Q1 		$15.5M Buy
186,924
+61,180
+49% +$5.76M 1.44% 34
2022
Q4 		$12.9M Sell
125,744
-3,089
-2% -$356K 1.29% 40
2022
Q3 		$13.7M Sell
128,833
-56,242
-30% -$6.16M 1.43% 31
2022
Q2 		$20.3M Buy
185,075
+4,979
+3% +$493K 2.02% 8
2022
Q1 		$18.8M Buy
180,096
+8,424
+5% +$875K 1.48% 22
2021
Q4 		$21M Sell
171,672
-53,811
-24% -$5.97M 1.59% 17
2021
Q3 		$25.9M Sell
225,483
-101,970
-31% -$10.8M 2% 5
2021
Q2 		$31.8M Sell
327,453
-45,056
-12% -$3.91M 2.41% 2
2021
Q1 		$27.5M Sell
372,509
-97,084
-21% -$7.22M 2.14% 5
2020
Q4 		$32M Sell
469,593
-104,283
-18% -$6.8M 2.3% 3
2020
Q3 		$33.5M Sell
573,876
-30,003
-5% -$1.58M 2.9% 1
2020
Q2 		$27.3M Buy
603,879
+153,181
+34% +$7.33M 2.33% 3
2020
Q1 		$26.1M Sell
450,698
-56,539
-11% -$3.87M 2.66% 3
2019
Q4 		$31.6M Sell
507,237
-16,216
-3% -$959K 2.21% 3
2019
Q3 		$30.1M Sell
523,453
-18,392
-3% -$1.02M 2.19% 4
2019
Q2 		$29.4M Sell
541,845
-203
-0% -$10.3K 2.07% 6
2019
Q1 		$25.5M Sell
542,048
-29,210
-5% -$1.62M 1.85% 12
2018
Q4 		$32.4M Buy
571,258
+5,570
+1% +$312K 2.97% 1
2018
Q3 		$30.9M Buy
565,688
+323
+0.1% +$18.5K 2.35% 1
2018
Q2 		$33.1M Sell
565,365
-2,660
-0.5% -$159K 2.6% 1
2018
Q1 		$32.2M Buy
568,025
+36,512
+7% +$1.99M 2.7% 1
2017
Q4 		$26.2M Sell
531,513
-14,856
-3% -$677K 2.28% 1
2017
Q3 		$25M Buy
546,369
+80,458
+17% +$3.07M 2.15% 3
2017
Q2 		$18.2M Buy
465,911
+48,478
+12% +$1.86M 1.6% 12
2017
Q1 		$16.9M Buy
417,433
+78,018
+23% +$3.06M 1.66% 13
2016
Q4 		$13.1M Buy
339,415
+39,662
+13% +$1.36M 1.53% 17
2016
Q3 		$9.55M Buy
299,753
+24,223
+9% +$920K 1.24% 28
2016
Q2 		$11M Buy
275,530
+37,972
+16% +$1.4M 1.61% 5
2016
Q1 		$7.98M Buy
237,558
+23,878
+11% +$683K 1.26% 15
2015
Q4 		$6.63M Sell
213,680
-7,658
-3% -$227K 1.1% 23
2015
Q3 		$6.64M Buy
221,338
+5,413
+3% +$179K 1.11% 24
2015
Q2 		$6.82M Sell
215,925
-95,535
-31% -$2.49M 1.06% 20
2015
Q1 		$7.18M Sell
311,460
-64,418
-17% -$1.33M 1.12% 15
2014
Q4 		$7.37M Buy
375,878
+98,210
+35% +$1.69M 1.25% 8
2014
Q3 		$4.36M Buy
277,668
+58,328
+27% +$831K 0.91% 26
2014
Q2 		$2.7M Buy
219,340
+2,474
+1% +$29.6K 0.54% 104
2014
Q1 		$2.98M Buy
216,866
+41,110
+23% +$592K 0.63% 89
2013
Q4 		$2.58M Buy
+175,756
New +$2.38M 0.51% 102

Other funds holding AMN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Tributary Capital Management's AMN Position: Q1 2026 in Review

Tributary Capital Management increased its AMN Healthcare (AMN) stake by 57% in Q1 2026, buying an estimated $4.14M and bringing the position to 598,497 shares worth $11M. The position accounts for 1.07% of the portfolio, ranked #46.

Tributary Capital Management first reported a position in AMN in Q4 2013 and has held it in 50 quarters since. The position peaked at $33.5M in Q3 2020. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • Tributary Capital Management held 598,497 shares of AMN Healthcare worth $11M as of Q1 2026.
  • Tributary Capital Management bought 217,968 AMN Healthcare shares in Q1 2026, an estimated $4.14M.
  • AMN Healthcare made up 1.07% of Tributary Capital Management's portfolio in Q1 2026, its #46 holding.
  • Tributary Capital Management first reported a position in AMN Healthcare in Q4 2013 and has held it in 50 quarters since.
  • Tributary Capital Management's AMN Healthcare position peaked at $33.5M in Q3 2020.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Tributary Capital Management's 13F filing for Q1 2026, filed 4 May 2026.